IDEAYA Biosciences has entered into a partnership with Genentech to conduct a clinical trial evaluating a targeted therapy for pancreatic cancer. The trial will assess the investigational treatment in a specific patient population.
Further details regarding trial design, timelines, or financial terms were not immediately available.
